118 related articles for article (PubMed ID: 23748247)
41. Modification and structure-activity relationship of a small molecule HIV-1 inhibitor targeting the viral envelope glycoprotein gp120.
Wang J; Le N; Heredia A; Song H; Redfield R; Wang LX
Org Biomol Chem; 2005 May; 3(9):1781-6. PubMed ID: 15858664
[TBL] [Abstract][Full Text] [Related]
42. gp120: Biologic aspects of structural features.
Poignard P; Saphire EO; Parren PW; Burton DR
Annu Rev Immunol; 2001; 19():253-74. PubMed ID: 11244037
[TBL] [Abstract][Full Text] [Related]
43. Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.
Andrianov AM; Kornoushenko YV; Anishchenko IV; Eremin VF; Tuzikov AV
J Biomol Struct Dyn; 2013; 31(7):665-83. PubMed ID: 22888999
[TBL] [Abstract][Full Text] [Related]
44. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
[TBL] [Abstract][Full Text] [Related]
45. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides.
Artan M; Karadeniz F; Karagozlu MZ; Kim MM; Kim SK
Carbohydr Res; 2010 Mar; 345(5):656-62. PubMed ID: 20117763
[TBL] [Abstract][Full Text] [Related]
46. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
[TBL] [Abstract][Full Text] [Related]
47. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
[TBL] [Abstract][Full Text] [Related]
48. The investigations on HIV-1 gp120 bound with BMS-488043 by using docking and molecular dynamics simulations.
Li L; Chen H; Zhao RN; Han JG
J Mol Model; 2013 Feb; 19(2):905-17. PubMed ID: 23086459
[TBL] [Abstract][Full Text] [Related]
49. The characteristic structure of anti-HIV actinohivin in complex with three HMTG D1 chains of HIV-gp120.
Zhang F; Hoque MM; Jiang J; Suzuki K; Tsunoda M; Takeda Y; Ito Y; Kawai G; Tanaka H; Takénaka A
Chembiochem; 2014 Dec; 15(18):2766-73. PubMed ID: 25403811
[TBL] [Abstract][Full Text] [Related]
50. Importance of V3 loop flexibility and net charge in the context of co-receptor recognition. A molecular dynamics study on HIV gp120.
Chandramouli B; Chillemi G; Abbate I; Capobianchi MR; Rozera G; Desideri A
J Biomol Struct Dyn; 2012; 29(5):879-91. PubMed ID: 22292949
[TBL] [Abstract][Full Text] [Related]
51. Kinetic Characterization of Novel HIV-1 Entry Inhibitors: Discovery of a Relationship between Off-Rate and Potency.
Meuser ME; Murphy MB; Rashad AA; Cocklin S
Molecules; 2018 Aug; 23(8):. PubMed ID: 30081466
[TBL] [Abstract][Full Text] [Related]
52. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
Williams DH; Adam F; Fenwick DR; Fok-Seang J; Gardner I; Hay D; Jaiessh R; Middleton DS; Mowbray CE; Parkinson T; Perros M; Pickford C; Platts M; Randall A; Siddle D; Stephenson PT; Tran TD; Vuong H
Bioorg Med Chem Lett; 2009 Sep; 19(17):5246-9. PubMed ID: 19620004
[TBL] [Abstract][Full Text] [Related]
53. A model of peptide triazole entry inhibitor binding to HIV-1 gp120 and the mechanism of bridging sheet disruption.
Emileh A; Tuzer F; Yeh H; Umashankara M; Moreira DR; Lalonde JM; Bewley CA; Abrams CF; Chaiken IM
Biochemistry; 2013 Apr; 52(13):2245-61. PubMed ID: 23470147
[TBL] [Abstract][Full Text] [Related]
54. Rational Design of Colchicine Derivatives as anti-HIV Agents via QSAR and Molecular Docking.
Worachartcheewan A; Songtawee N; Siriwong S; Prachayasittikul S; Nantasenamat C; Prachayasittikul V
Med Chem; 2019; 15(4):328-340. PubMed ID: 30251609
[TBL] [Abstract][Full Text] [Related]
55. Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replication.
Serradji N; Bensaid O; Martin M; Kan E; Dereuddre-Bosquet N; Redeuilh C; Huet J; Heymans F; Lamouri A; Clayette P; Dong CZ; Dormont D; Godfroid JJ
J Med Chem; 2000 Jun; 43(11):2149-54. PubMed ID: 10841793
[TBL] [Abstract][Full Text] [Related]
56. Inhibitors of HIV-1 attachment: The discovery and structure-activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore.
Swidorski JJ; Liu Z; Yin Z; Wang T; Carini DJ; Rahematpura S; Zheng M; Johnson K; Zhang S; Lin PF; Parker DD; Li W; Meanwell NA; Hamann LG; Regueiro-Ren A
Bioorg Med Chem Lett; 2016 Jan; 26(1):160-7. PubMed ID: 26584882
[TBL] [Abstract][Full Text] [Related]
57. Prediction of HIV-1 entry inhibitors neomycin-arginine conjugates interaction with the CD4-gp120 binding site by molecular modeling and multistep docking procedure.
Berchanski A; Lapidot A
Biochim Biophys Acta; 2007 Sep; 1768(9):2107-19. PubMed ID: 17560540
[TBL] [Abstract][Full Text] [Related]
58. Discovery of the Human Immunodeficiency Virus Type 1 (HIV-1) Attachment Inhibitor Temsavir and Its Phosphonooxymethyl Prodrug Fostemsavir.
Wang T; Ueda Y; Zhang Z; Yin Z; Matiskella J; Pearce BC; Yang Z; Zheng M; Parker DD; Yamanaka GA; Gong YF; Ho HT; Colonno RJ; Langley DR; Lin PF; Meanwell NA; Kadow JF
J Med Chem; 2018 Jul; 61(14):6308-6327. PubMed ID: 29920093
[TBL] [Abstract][Full Text] [Related]
59. Anti-HIV-1 activity in vitro of ceftazidime degradation products.
Hobi R; Hübscher U; Neftel K; Alteri E; Poncioni B; Walker MR; Woods-Cook K; Schneider P; Lazdins JK
Antivir Chem Chemother; 2001 Mar; 12(2):109-18. PubMed ID: 11527042
[TBL] [Abstract][Full Text] [Related]
60. Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.
Lai YT; Wang T; O'Dell S; Louder MK; Schön A; Cheung CSF; Chuang GY; Druz A; Lin B; McKee K; Peng D; Yang Y; Zhang B; Herschhorn A; Sodroski J; Bailer RT; Doria-Rose NA; Mascola JR; Langley DR; Kwong PD
Nat Commun; 2019 Jan; 10(1):47. PubMed ID: 30604750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
